Literature DB >> 18160445

The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth.

William C Spanos1, Andrew Hoover, George F Harris, Shu Wu, Guinevere L Strand, Mary E Anderson, Aloysius J Klingelhutz, Wiljan Hendriks, Aaron D Bossler, John H Lee.   

Abstract

The human papillomavirus (HPV) oncogene E6 has been shown to perform multiple functions (p53 degradation, telomerase activation, etc.) that play a role in oncogenic transformation. Beyond known E6 functions, an undefined mechanism that allows cellular invasion requires the E6 PDZ binding motif (PDZBM). Here, we show that HPV type 16 (HPV16) E6 interacts with and induces loss of a protein tyrosine phosphatase (PTPN13) in a PDZBM-dependent manner. PTPN13 loss induced either by the presence of E6 or by a short hairpin RNA strategy allows for anchorage-independent growth (AIG) and synergy with a known oncogene, Ras(v12), resulting in invasive growth in vivo. Restoring PTPN13 expression reverses AIG in cells lacking PTPN13. A genomic analysis of colorectal carcinoma has identified an association between PTPN13 loss-of-function mutations and aberrant Ras signaling. Our findings support this correlation and provide methods for further evaluation of the mechanisms by which PTPN13 loss/Ras expression leads to invasive growth, the results of which will be important for treatment of HPV-related and non-HPV cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160445      PMCID: PMC2258903          DOI: 10.1128/JVI.02188-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins.

Authors:  S S Lee; B Glaunsinger; F Mantovani; L Banks; R T Javier
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

2.  Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.

Authors:  Kristi L Berger; Felicia Barriga; Michael J Lace; Lubomir P Turek; Gideon J Zamba; Frederick E Domann; John H Lee; Aloysius J Klingelhutz
Journal:  Virology       Date:  2006-08-30       Impact factor: 3.616

3.  Opposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis.

Authors:  Vladimir N Ivanov; Ze'ev Ronai; Tom K Hei
Journal:  J Biol Chem       Date:  2005-11-23       Impact factor: 5.157

4.  Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome.

Authors:  M Frisch; R J Biggar; J J Goedert
Journal:  J Natl Cancer Inst       Date:  2000-09-20       Impact factor: 13.506

Review 5.  Epidermal growth factor receptor biology in head and neck cancer.

Authors:  Shailaja Kalyankrishna; Jennifer R Grandis
Journal:  J Clin Oncol       Date:  2006-06-10       Impact factor: 44.544

6.  Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential.

Authors:  Sara J S Simonson; Michael J Difilippantonio; Paul F Lambert
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

7.  Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.

Authors:  Shi-Long Lu; Heather Herrington; Douglas Reh; Stephen Weber; Sophia Bornstein; Donna Wang; Allen G Li; Chin-Fang Tang; Yasmin Siddiqui; Jo Nord; Peter Andersen; Christopher L Corless; Xiao-Jing Wang
Journal:  Genes Dev       Date:  2006-05-15       Impact factor: 11.361

8.  Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins.

Authors:  Ming Jing; Joanna Bohl; Nicole Brimer; Michael Kinter; Scott B Vande Pol
Journal:  J Virol       Date:  2006-12-13       Impact factor: 5.103

9.  Deletion of the PDZ motif of HPV16 E6 preventing immortalization and anchorage-independent growth in human tonsil epithelial cells.

Authors:  William C Spanos; Jeremy Geiger; Mary E Anderson; George F Harris; Aaron D Bossler; Russell B Smith; Aloysius J Klingelhutz; John H Lee
Journal:  Head Neck       Date:  2008-02       Impact factor: 3.147

10.  The role of human papillomavirus 16 E6 in anchorage-independent and invasive growth of mouse tonsil epithelium.

Authors:  Andrew C Hoover; William C Spanos; George F Harris; Mary E Anderson; Aloysius J Klingelhutz; John H Lee
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-05
View more
  66 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.

Authors:  Murielle Glondu-Lassis; Mathilde Dromard; Magali Lacroix-Triki; Philippe Nirdé; Carole Puech; Dora Knani; Dany Chalbos; Gilles Freiss
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

Review 3.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

Review 4.  Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses.

Authors:  Ronald T Javier; Andrew P Rice
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

5.  miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1.

Authors:  Robert Schickel; Sun-Mi Park; Andrea E Murmann; Marcus E Peter
Journal:  Mol Cell       Date:  2010-06-25       Impact factor: 17.970

6.  Sickness behavior induced by cisplatin chemotherapy and radiotherapy in a murine head and neck cancer model is associated with altered mitochondrial gene expression.

Authors:  Elisabeth G Vichaya; Jessica M Molkentine; Daniel W Vermeer; Adam K Walker; Rebekah Feng; Gerard Holder; Katherine Luu; Ryan M Mason; Leo Saligan; Cobi J Heijnen; Annemieke Kavelaars; Kathy A Mason; John H Lee; Robert Dantzer
Journal:  Behav Brain Res       Date:  2015-10-22       Impact factor: 3.332

7.  The HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42.

Authors:  A W Oliver; X He; K Borthwick; A J Donne; L Hampson; I N Hampson
Journal:  Br J Cancer       Date:  2010-12-07       Impact factor: 7.640

8.  Roles of the PDZ domain-binding motif of the human papillomavirus type 16 E6 on the immortalization and differentiation of primary human foreskin keratinocytes.

Authors:  Moonju Choi; Sungjin Lee; Taekyu Choi; Choongho Lee
Journal:  Virus Genes       Date:  2013-11-29       Impact factor: 2.332

9.  Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway.

Authors:  A C Hoover; G L Strand; P N Nowicki; M E Anderson; P D Vermeer; A J Klingelhutz; A D Bossler; J V Pottala; W J A J Hendriks; J H Lee
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

Review 10.  Protein tyrosine phosphatases in glioma biology.

Authors:  Anna C Navis; Monique van den Eijnden; Jan T G Schepens; Rob Hooft van Huijsduijnen; Pieter Wesseling; Wiljan J A J Hendriks
Journal:  Acta Neuropathol       Date:  2009-11-21       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.